Original Research

APOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the µ-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy

Viscusi ER, Skobieranda F, Soergel DG, Cook E, Burt DA, Singla N

Journal of Pain Research 2019, 12:927-943

Published Date: 11 March 2019